Buy Methocarbamol Online

METHOCARBAMOL

Methocarbamol Pain Medication Prescription Drug Information: Methocarbamol tablets USP a carbamate derivative of guaifenesin, is a central nervous system (CNS) depressant with sedative and musculoskeletal relaxant properties. Methocarbamol tablets USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. Online Order Form

Quantity	Price	Ship	Order
Fioricet 50mg (Generic)
120 Tabs	$175	Free	Order Online
90 Tabs	$163	Free
60  Tabs	$149	Free
30  Tabs	$131	Free

ROBAXIN-METHOCARBAMOL DRUG INFO

IMPORTANT NOTE: The information contained here is only a supplement. It is not a substitute for the expertise and judgment of your doctor, other healthcare professional or pharmacist. Do not construe that the use of the drug is safe, effective, or appropriate for you. Before using this drug consult your healthcare professional.

METHOCARBAMOL - ORAL & PAIN RELIEF) (meth-uh-kahr-buh-mawl, -mol)

COMMON BRAND NAME(S): Robaxin

DRUG USES
Methocarbamol tablets USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.

HOW TAKEN
Methocarbamol Tablets USP 500 mgAdults:
Initial dosage: 3 tablets q.i.d.
Maintenance dosage: 2 tablets q.i.d.
Methocarbamol Tablets USP 750 mgAdults:
Initial dosage: 2 tablets q.i.d.
Maintenance dosage: 1 tablet q.4h. or 2 tablets t.i.d.
Six grams a day are recommended for the first 48 to 72 hours of treatment. (For severe conditions 8 grams a day may be administered). Thereafter, the dosage can usually be reduced to approximately 4 grams a day.

WARNINGS
Since methocarbamol may possess a general CNS depressant effect, patients receiving methocarbamol tablets USP should be cautioned about combined effects with alcohol and other CNS depressants.
Safe use of methocarbamol tablets USP has not been established with regard to possible adverse effects upon fetal development. There have been reports of fetal and congenital abnormalities following in utero exposure to methocarbamol. Therefore, methocarbamol tablets USP should not be used in women who are or may become pregnant and particularly during early pregnancy unless in the judgment of the physician the potential benefits outweigh the possible hazards (seePRECAUTIONS, Pregnancy).
Use In Activities Requiring Mental Alertness
Methocarbamol may impair mental and/or physical abilities required for performance of hazardous tasks, such as operating machinery or driving a motor vehicle. Patients should be cautioned about operating machinery, including automobiles, until they are reasonably certain that methocarbamol therapy does not adversely affect their ability to engage in such activities.

PRECAUTIONS
Patients should be cautioned that methocarbamol may cause drowsiness or dizziness, which may impair their ability to operate motor vehicles or machinery. Because methocarbamol may possess a general CNS-depressant effect, patients should be cautioned about combined effects with alcohol and other CNS depressants.

ADVERSE REACTIONS
Adverse reactions reported coincident with the administration of methocarbamol include:
Body as a whole: Anaphylactic reaction, angioneurotic edema, fever, headache
Cardiovascular system: Bradycardia, flushing, hypotension, syncope, thrombophlebitis
Digestive system: Dyspepsia, jaundice (including cholestatic jaundice), nausea and vomiting
Hemic and lymphatic system: Leukopenia
Immune system: Hypersensitivity reactions
Nervous system: Amnesia, confusion, diplopia, dizziness or lightheadedness, drowsiness, insomnia, mild muscular incoordination, nystagmus, sedation, seizures (including grand mal), vertigo
Skin and special senses: Blurred vision, conjunctivitis, nasal congestion, metallic taste, pruritus, rash, urticaria

STORAGE
Keep out of the reach and sight of children.
Store at 20to 25(68to 77[see USP Controlled Room Temperature].
Dispense in tight container

OVERDOSAGE
Limited information is available on the acute toxicity of methocarbamol. Overdose of methocarbamol is frequently in conjunction with alcohol or other CNS depressants and includes the following symptoms: nausea, drowsiness, blurred vision, hypotension, seizures, and coma. In post-marketing experience, deaths have been reported with an overdose of methocarbamol alone or in the presence of other CNS depressants, alcohol or psychotropic drugs.
Treatment
Management of overdose includes symptomatic and supportive treatment. Supportive measures include maintenance of an adequate airway, monitoring urinary output and vital signs, and administration of intravenous fluids if necessary. The usefulness of hemodialysis in managing overdose is unknown.

DISCLAIMER
This online prescription drug information is for information purposes only. The content presented here does not cover all uses, drug interactions, precautions, directions, or adverse effects of the aforementioned medication. This online pharmacy provides this information as general information only. Do not rely on any information on this online pharmacy website for any other purpose. It shouldn't be construed as containing specific instructions for any particular patient. We disclaim all responsibility for the reliability and accuracy of this online prescription drug information, and or any consequences arising from the use of this information, including adverse consequences or damage to property or persons, however such consequences or damages arise. No warranty, either implied or expressed, is made in regards to this information.

[Top]